Daniel Lysák

2.9k citations
87 papers · 2.3k · 3 hit papers · h-index 20

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 2%
    • Chronic Lymphocytic Leukemia Research
    • Mesenchymal stem cell research

Papers in

    • Chronic Lymphocytic Leukemia Research 23
    • Mesenchymal stem cell research 8
    • Hematopoietic Stem Cell Transplantation 14
    • Acute Myeloid Leukemia Research 11

Daniel Lysák

77 papers receiving 2.3k citations

Daniel Lysák's Hit Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia 2025 · 56 citations
560+4+9Years since publication250500750

Peers

Daniel Lysák
Comparison fields: 5 of 80
  • Hematology 1.1k
  • Genetics 551
  • Oncology 157
  • Immunology 128
  • Nephrology 47
Replace David Marin with:
David Marin United Kingdom
Marc Bernard France
Robin Filshie Australia
Mourad Tiab France
Thomas J. Nevill Canada
Stéphanie Harel France
Sumithira Vasu United States
Brigitte Kolb France
Amer Assal United States
Marie‐Sarah Dilhuydy France
Daniel Lysák relative to David Marin United Kingdom David Marin's profile →
Citations per field
00.5×2×3×4.3×
David Marin · 1×
Citations per year

Countries citing papers authored by Daniel Lysák

Since Specialization
Citations

This map shows the geographic impact of Daniel Lysák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lysák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lysák more than expected).

Fields of papers citing papers by Daniel Lysák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lysák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lysák. The network helps show where Daniel Lysák may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Lysák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Lysák Line = papers co-authored together Daniel Lysák links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Hit paper breakdown →
2012986
2
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Hit paper breakdown →
2020308
3 202280
4
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
Hit paper breakdown →
202556
5 201052
6 201950
7 200547
8 202144
9 201438
10 201529
11 201629
12 201929
13 201028
14 201127
15 201324
16 201924
17 201622
18 201021
19 201220
20 201820

About Daniel Lysák

Daniel Lysák is a scholar working on Genetics, Hematology, Immunology, Oncology and Hepatology, having authored 87 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (11 papers), Mesenchymal stem cell research (8 papers), Immune Cell Function and Interaction (8 papers), Cytomegalovirus and herpesvirus research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (551 citations), Oncology (157 citations), Immunology (128 citations) and Nephrology (47 citations). Daniel Lysák has collaborated with scholars based in Czechia, United States and United Kingdom. Frequent co-authors include Pavel Jindra, Jaroslav Čermák, Grzegorz J. Mazur, Albert Oriol, Agnieszka Wierzbowska, Farhad Ravandi, Hagop M. Kantarjian, Anna Dmoszyńska, Jyh‐Pyng Gau and Stefan H Faderl. Their work appears in journals such as Hematological Oncology, Annals of Hematology, Journal of Clinical Medicine, Bone Marrow Transplantation and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact